AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000,000 | +48.1% | 488,500 | 0.0% | 0.18% | -0.5% |
Q4 2018 | $2,701,000 | +2.0% | 488,500 | +62.8% | 0.19% | +22.4% |
Q3 2018 | $2,649,000 | -3.7% | 300,000 | +8.8% | 0.15% | -5.6% |
Q2 2018 | $2,751,000 | -4.4% | 275,700 | -8.7% | 0.16% | -12.5% |
Q1 2018 | $2,879,000 | +66.4% | 302,100 | +159.5% | 0.18% | +97.8% |
Q4 2017 | $1,730,000 | +176.8% | 116,400 | +266.0% | 0.09% | +173.5% |
Q3 2017 | $625,000 | +37.1% | 31,800 | 0.0% | 0.03% | +21.4% |
Q2 2017 | $456,000 | -2.8% | 31,800 | -38.7% | 0.03% | -26.3% |
Q3 2016 | $469,000 | – | 51,900 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |